| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | +17.1% |
| Cost of Revenue | $654K | +17.8% |
| Gross Profit | $539K | +16.2% |
| R&D Expense | $1.2M | -33.9% |
| SG&A Expense | $7.0M | -14.9% |
| Operating Income | -$7.7M | +20.1% |
| Interest Expense | $4K | +100.0% |
| Net Income | -$7.7M | +20.5% |
| EPS (Basic) | -$11.51 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +13.0% |
| Accounts Receivable | $95K | -15.9% |
| Inventory | $795K | -6.8% |
| Current Assets | $6.7M | +9.1% |
| Total Assets | $7.3M | +7.5% |
| Current Liabilities | $786K | -40.6% |
| Total Liabilities | $942K | -37.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.6M | +11.8% |
| Capital Expenditures | $149K | -14.4% |
| Investing Cash Flow | -$149K | +12.4% |
| Financing Cash Flow | $8.3M | +98.6% |
| Free Cash Flow | -$7.7M | +11.8% |
| +25.7% |
| EPS (Diluted) | -$11.51 | +25.7% |
| Stockholders' Equity |
| $6.4M |
| +20.3% |